The antiviral drug docosanol as a treatment for Kaposi's sarcoma lesions in HIV type 1-infected patients: A pilot clinical study

AIDS Research and Human Retroviruses

Volumn 17, Issue 1, 2001, Pages 35-43

  Scolaro, M J ^a   Gunnill, L B ^b   Pope, L E ^b   Khalil, M H ^b   Katz, D H ^b   Berg, J E ^b  

^a The Scolaro Medical Coalition   (United States)

^b AVANIR PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BEHENYL ALCOHOL;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL; SKIN EDEMA; TREATMENT OUTCOME; VIRUS LOAD;

ADMINISTRATION, TOPICAL; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; FATTY ALCOHOLS; HIV-1; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SARCOMA, KAPOSI; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0035141656     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201750056762     Document Type: Article

References (32)

1. Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex
2. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: Multicenter, randomized, placebo-controlled trials
3. n-Docosanol 10% cream in the treatment of recurrent herpes labialis: A randomised, double-blind, placebo-controlled study
4. Final report of the safety assessment of cetearyl alcohol, cetyl alcohol, isostearyl alcohol, myristyl alcohol, and behenyl alcohol
5. n-Docosanol: Broad spectrum anti-viral activity against lipid-enveloped viruses
6. n-Docosanol inhibits in vitro replication of HIV and other retroviruses
7. Anti-herpes simplex virus activity of n-docosanol correlates with intracellular metabolic conversion of the drug
8. Lidakol®
9. The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process
10. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS: Multistate AIDS/Cancer Match Study Group
11. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection?
12. The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco
13. Kaposi's sarcoma as a sexually transmissible infection: An analysis of Australian AIDS surveillance data
14. KSHV and Kaposi's sarcoma: The end of the beginning?
15. Three new human herpesviruses (HHV6, 7, and 8)
16. Kaposi's sarcoma: Advances and perspectives
17. Identification of herpes-like DNA sequences in AIDS-associated Kaposi's sarcoma
18. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma patients with and those without HIV infection
19. Treatment of epidemic (AIDS-related) Kaposi's sarcoma
20. Intentions and outcomes in the radiotherapeutic management of epidemic Kaposi's sarcoma
21. A randomized prospective trial of radiation therapy for AIDS-associated Kaposi's sarcoma
22. Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin
23. Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma using bleomycin-containing combination chemotherapy regimens
24. Pharmacology of liposomal daunorubicin and its use in Kaposi's sarcoma
25. Treatment of classic Kaposi's sarcoma with liposomal encapsulated doxorubicin
26. Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma
27. Effect of whole-body hyperthermia on AIDS patients with Kaposi's sarcoma: A pilot study
28. 2b and zidovudine in early-stage AIDS-associated Kaposi's sarcoma
29. Clearance given for Panretin gel
30. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor
31. Kaposi's sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response, and staging criteria
32. Kaposi's sarcoma response criteria: Issues identified by the National Cancer Institute. Food and Drug Administration, and The AIDS Malignancy Consortium